GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (FRA:OC50) » Definitions » Purchase Of Investment

Cochlear (FRA:OC50) Purchase Of Investment : €-10 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cochlear Purchase Of Investment?

Cochlear's purchase of investment for the six months ended in Jun. 2024 was €-7 Mil. It means Cochlear spent €7 Mil on purchasing investments. Cochlear's purchase of investment for the trailing twelve months (TTM) ended in Jun. 2024 was €-10 Mil.

Compared with last quarter (€-3 Mil in Dec. 2023 ), Cochlear spent more money on purchasing investments in Jun. 2024 (€-7 Mil).

Cochlear Purchase Of Investment Historical Data

The historical data trend for Cochlear's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Purchase Of Investment Chart

Cochlear Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -232.39 -11.68 -41.02 -18.46 -9.81

Cochlear Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.90 -40.26 20.69 -3.13 -6.66

Cochlear Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cochlear Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Cochlear's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Cochlear Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (FRA:OC50) » Definitions » Purchase Of Investment
Comparable Companies
ASX:PNV ASX:IMR ASX:ARX ASX:AVR ASX:4DX ASX:EMV ASX:CYC ASX:IPD ASX:RSH ASX:NTI ABT SYK BSX MDT XTER:SHL SZSE:300760 EW DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
CHEOY:USA CHEOF:USA OC5:Germany COH:Australia
Address
1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Website
https://www.cochlear.com
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

Cochlear Headlines

No Headlines